/stocks — the workspaceLOADING
Stereotaxis, Inc. (STXS) is a electromedical & electrotherapeutic apparatus company. Piotroski F-Score 4/7. 6 insider Form 4 filings in the last 90 days. Next earnings scheduled for 2026-08-11 per a third-party calendar (not filing-confirmed). Fundamentals from SEC filings; prices are end-of-day.
What’s behind STXS’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from STXS’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
A plain-English read on STXS plus an auto-SWOT — built from STXS's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate STXS using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Has STXS been issuing shares? Offering history →
This date came from a third-party earnings calendar, linked above, not from STXS's own filings or investor-relations announcement. We cannot show you a primary document behind it, so we do not call it confirmed and it does not carry our full confidence rating. Treat it as a useful pointer rather than a verified fact — when STXS files or announces, this page upgrades itself automatically.
Projected from STXS's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentSTXS files or announces.
STXS has sold off after 5 of its last 8 earnings reports.
Each figure is one earnings reaction — how much STXS moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Large earnings reactions have been common.
STXS has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+18.9% and -21.4%).
A more typical earnings reaction has been approximately ±9.3%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-12 | -1.6% |
| 2026-03-09 | -3.9% |
| 2025-11-12 | -21.4% |
| 2025-08-07 | +11.1% |
| 2025-05-12 | -0.9% |
| 2025-03-03 | -12.6% |
| 2024-11-12 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +18.9% |
| 2024-08-12 | +7.5% |